07.100.10 医学微生物学 标准查询与下载

DIN 58943-4:2009 医用微生物学.结核病的诊断.第4部分:肺结核和结核分枝杆菌的诊断用初次样品.开采、运输和储存用定性和定量要求

This standard applies to the extraction, transport, acceptance and checking of specimens used for the detection of mycobacteria.

Medical microbiology - Diagnosis of tuberculosis - Part 4: Primary samples for the diagnosis of tuberculosis and mycobacteria - Qualitative and quantitative requirements, extraction, transport and storage; Text in German and English

ANSI/NSF 49(i28)-2009 生物安全柜:设计,施工,性能和现场检定

Biosafety Cabinetry: Design, Construction, Performance, and Field Certification

ANSI/NSF 49(i34)-2009 生物安全柜:设计,制造,性能和现场检定

Biosafety Cabinetry: Design, Construction, Performance, and Field Certification

ANSI/NSF 49(i35)-2009 生物安全性家具:设计、构造、性能和现场认证

Biosafety Cabinetry: Design, Construction, Performance, and Field Certification

ANSI/NSF 49(i36)-2009 生物安全柜:设计,结构,性能和现场检定

Biosafety Cabinetry: Design, Construction, Performance, And Field Certification

SANS 5553:2008 微生物检测介质和试剂

Specifies the quality of ingredients and the general method to be used in the preparation of media and reagents for microbiological tests in which the use of different formulations and ingredients might influence the results of the test.

Media and reagents for microbiological tests

DIN 58942-6:2008 医学微生物学.培养基.第6部分:固体发色培养基

This standard applies to chromogenic culture media.

Medical microbiology - Culture media - Part 6: Solid chromogenic culture media; Text in German and English

ANSI/NSF 49(i15r2)-2008 生物安全柜:设计,制作,性能和行业认证

Biosafety Cabinetry: Design, Construction, Performance, and Field Certification

ANSI/NSF 49(i15)-2008 生物安全家具:设计、构造、性能和现场认证

Biosafety Cabinetry: Design, Construction, Performance, and Field Certification

ANSI/NSF 49(i30)-2008 II级(层流)细木家具生物研究安全性

Class II (laminar flow) biosafety cabinetry

ASTM E1326-08 评价细菌计数用非常规微生物试验的标准指南

This guide should be used by producers and potential producers of nonconventional tests to determine the accuracy, selectivity, specificity, and reproducibility of the tests, as defined in Practices E 691 and D 3870. Results of such studies should identify the limitations and indicate the utility or applicability of the nonconventional test, or both, for use on different types of samples. Nonconventional test users and potential users should employ this guide to evaluate results of the nonconventional test as compared to their present methods. Practices D 5245 and D 5465 should be reviewed in regards to the conventional microbiological methods employed. If conventional methods have not been used for monitoring the systems, then guidelines are included for obtaining microbiological expertise. Utilization of a nonconventional test may reduce the time required to determine the microbiological status of the system and enable an improvement in the overall operating efficiency. In many cases, the findings of a significantly high level of bacteria indicates the need for an addition of an antimicrobial agent. By accurately determining this in a shorter time period than by conventional methods, treatment with antimicrobial agents may circumvent more serious problems than if the treatment were postponed until conventional results were available. If the antimicrobial treatment program relies on an inaccurate nonconventional test, then unnecessary loss of product and problems associated with inappropriate selection or improper dosing with antimicrobial agents would exist. Since many methods based on entirely different chemical and microbiological principles are considered, it is not possible to establish a unique design and recommend a specific method of statistical analyses for the comparisons to be made. It is only possible to present guides that should be followed while performing the experiments. It is also recommended that a statistician be involved in the study. 1.1 The purpose of this guide is to assist users and producers of nonconventional tests in determining the applicability of the test for processing different types of samples and evaluating the accuracy of the results. Conventional procedures such as the Heterotrophic (Standard) Plate Count, the Most Probable Number (MPN) method and the Spread Plate Count are widely cited and accepted for the enumeration of microorganisms. However, these methods have their limitations, such as performance time and degree of accuracy. It is these limitations that have recently led to the marketing of a variety of non-conventional procedures, test kits and instruments. 1.2 A conventional test is one that is widely accepted and published as a standard microbiological method or related procedure. A new, nonconventional test method will attempt to provide the same information through the measurement of a different parameter. This guide is designed to assist investigators in assessing the accuracy and precision of nonconventional methods intended for the determination of microbial population densities or activities. 1.3 It is recognized that the Heterotrophic Plate Count does not recover all microorganisms present in a product or a system (1, 2). When this problem occurs during the characterization of a microbiological population, alternative standard enumeration procedures may be necessary, as in the case of sulfate-reducing bacteria. At other times, chemical methods that measure the rates of appearance of metabolic derivatives or the utilization of contaminated product components might be indicated. In evaluating nonconventional tests, the use of these alternative standard procedures may be the only means available for establishing correlation. In such cases, this guide can serve as a ref......

Standard Guide for Evaluating Nonconventional Microbiological Tests Used for Enumerating Bacteria

ANSI/NSF 49(i26)-2008 II级(层流)细木家具生物研究安全性

Class II (laminar flow) biosafety cabinetry

ASTM D5952-08(2015) 军团菌水系统检查和军团病突然爆发调查的标准指南 (军团病或庞蒂亚克热)

5.1 Water systems may be inspected (see Section 7) and tested (see Section 8) for legionella under three circumstances (1) in the absence of reported legionellosis (see 5.2); (2) when a single legionellosis case has been reported (see 5.3); and (3) when two or more legionellosis cases are reported in a limited time period and geographic region (see 5.4). Following are factors building owners and operators need to understand when considering testing water systems for legionella in the absence of illness (see 5.2) and for single legionellosis cases (see 5.3). Refer also to the CDC 2003 Guidelines for Preventing Health-Care Associated Pneumonia, and the CDC 2000 Guidelines for Preventing Opportunistic Infections Among Hematopoietic Stem Cell Transplant Recipients, and the WHO Legionella and the Prevention of Legionellosis. Detection of legionella in a water system is not sufficient to identify the system as a health hazard. However, failure to detect legionella does not indicate, conclusively, that the bacterium is not present (see 6.2.4) or that the water system may not pose a potential health hazard. Methods to detect legionella vary in sensitivity and specificity (see 6.2), and laboratories vary in their skill and experience in the isolation and identification of legionella. Isolation of apparently identical legionellae from clinical and environmental samples (see 6.2.1, 6.6.2.4, and Section 8) may suggest that a water system was the source of the legionella responsible for a patient's infection (see 5.3.2). However, cases of Legionnaires' disease due to different legionella serogroups or species need not necessarily have different sources of exposure because a system may be contaminated by more than one legionella. Timely inspection, testing, and treatment of possible legionella sources may reduce legal liabilities for facility owners and operators. Refer also to the APHA Public Health Law Manual. 5.2 Environmental Testing for Legionella in the Absence of Illness:  5.2.1 Concerned employers, building owners and operators, facility managers, and others seek to prevent real and potential health hazards, if possible. Water system operators may identify undesirable situations by monitoring routinely for legionella and may be able to implement control measures before the bacterium reaches an amount sufficient to cause human illness (see 6.2.4.2). The CDC 2000 Guidelines for Preventing Opportunistic Infections Among Hematopoietic Stem Cell Transplant Recipients advises that because transplant recipients are at much higher risk for disease and death from legionellosis compared with other hospitalized persons, periodic culturing for legionella in water samples from a center's potable water supply could be regarded as part of an overall strategy for the prevention of Legionnaires' disease in transplant centers and oth......

Standard Guide for the Inspection of Water Systems for Legionella and the Investigation of Possible Outbreaks of Legionellosis (Legionnaires' Disease or Pontiac Fever)

ASTM E2525-08 评定纳米粒子材料费对老鼠粒细胞巨噬细胞集落形成影响的标准试验方法

Stem cells of hematopoietic origin are pluripotential and may be particularly sensitive to the effects of stimulation by nanoparticulate materials. The effect of particles on macrophage responses has an extensive history and can be assessed by Practice F 1903. The test method described here will assess the effect on stem cells which can be progenitor cells to the macrophage line.1.1 This test method provides a protocol for quantitative analysis of the effect of nanoparticulate materials in physiologic solution on granulocyte-macrophage colony-forming units. 1.2 This test method employs murine bone marrow hematopoietic stem cells which proliferate and differentiate to form discrete cell clusters or colonies which are counted. 1.3 This test method is part of the in vitro preclinical characterization cascade for nanoparticulate materials for systemic administration in medical applications. 1.4 This standard does not purport to address all of the safety concerns, if any, associated with its use. It is the responsibility of the user of this standard to establish appropriate safety and health practices and determine the applicability of regulatory limitations prior to use.

Standard Test Method for Evaluation of the Effect of Nanoparticulate Materials on the Formation of Mouse Granulocyte-Macrophage Colonies

DIN-Fachbericht 157:2007 临床相关酵母用符合DIN58940标准的氟康唑最低抑制浓度(MIC)和抑菌圈直径(IZD)评估标准的基本原理和对照菌株用氟康唑的控制极限规范

Rationale for assessment criteria for minimum inhibitory concentration (MIC) and inhibition zone diameter (IZD) of fluconazole according to DIN 58940 for clinically relevant yeasts, and specification of fluconazole control limits for control strains

DIN 58943-9:2007 医用微生物学.结核病的诊断.第9部分:结核杆菌的表型变异

Medical microbiology - Diagnostics of tuberculosis - Part 9: Phenotypic differentiation of tubercle bacilli; text in German and English

DIN 58940-6:2007 医用微生物学.病原体对抗菌剂的敏感性测试.第6部分:用琼脂稀释法测定最小抑制浓度

This standard specifies a test method for the determination of the moisture content of sanitary papers.

Medical microbiology - Susceptibility testing of microbial pathogens to antimicrobial agents - Part 6: Determination of the minimum inhibitory concentration (MIC) with the agar dilution method; Text in German and English

DIN 58940-3:2007 医学微生物学.病原体对抗微生物剂的敏感性测试.第3部分:琼脂扩散试验

Medical microbiology - Susceptibility testing of microbial pathogens to antimicrobial agents - Part 3: Agar diffusion test; Text in German and English

DIN 58940-2:2007 医学微生物学.病原体对抗微生物剂的敏感性测试.第2部分:琼脂扩散试验用活性物质载体

Medical microbiology - Susceptibility testing of microbial pathogens to antimicrobial agents - Part 2: Active substance carriers for the agar diffusion test; Text in German and English

DIN 58940-31:2007 医学微生物学.微生物病源细菌对杀菌剂敏感性的检测.第31部分:敏感性补充方法.德文和英文本

Medical microbiology - Susceptibility testing of microbial pathogens to antimicrobial agents - Part 31: Supplementing methods for susceptibility testing; Text in German and English